Clinical Trial Update: Study of EBT-101 in Aviremic HIV-1 Infected Adults on Stable ART [Phase 1]

View source ↗

Summary

Excision BioTherapeutics reports the completion of a Phase 1 trial evaluating EBT-101 in aviremic HIV-1-infected adults on stable antiretroviral therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• EBT-101

Snippet

Sponsor: Excision BioTherapeutics | Conditions: HIV-1-infection | Phase 1 | Status: COMPLETED